Centivax Initiates Phase 1 First-in-Human Clinical Trial of Universal Flu Vaccine
PR Newswire —
SOUTH SAN FRANCISCO, Calif., Feb. 12, 2026 /PRNewswire/ -- Centivax, Inc., a clinical-stage biotechnology company engineering vaccines and therapies for durable, universal protection against highly diverse targets, today announced that the first participants have been dosed in the...